Q87.81 Alport syndrome

Name of the Condition

• Alport syndrome

Summary

Alport syndrome is a genetic disorder characterized by progressive kidney disease, often accompanied by hearing loss and eye abnormalities. It primarily affects the glomerular basement membrane, leading to structural changes in the kidneys, ears, and eyes. The condition can vary in severity, with some individuals experiencing early-onset renal failure, while others have milder or delayed symptoms.

Causes

Alport syndrome is caused by mutations in genes responsible for producing type IV collagen, a protein essential for the structural integrity of basement membranes. Most cases are inherited in an X-linked pattern (COL4A5 gene), though autosomal recessive (COL4A3 or COL4A4 genes) and autosomal dominant forms also occur. These genetic defects disrupt the normal function of the glomerular basement membrane, leading to kidney damage over time.

Risk Factors

• Family history of Alport syndrome or related kidney disease.
• Male gender (for X-linked inheritance, as males are more severely affected).
• Consanguinity (increased risk of autosomal recessive inheritance).

Symptoms

• Hematuria (blood in urine), often starting in childhood.
• Progressive kidney function decline, potentially leading to end-stage renal disease.
• Sensorineural hearing loss, typically in late childhood or adolescence.
• Eye abnormalities, such as anterior lenticonus or retinal flecks.
• High blood pressure in advanced cases.

Diagnosis

Diagnosis involves a combination of clinical evaluation, family history, and laboratory tests. Urinalysis may show hematuria or proteinuria. Kidney biopsy with electron microscopy can reveal characteristic changes in the glomerular basement membrane. Genetic testing confirms the diagnosis by identifying mutations in the relevant collagen genes. Audiological and ophthalmological assessments help evaluate associated symptoms.

Treatment Options

• Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) to slow kidney disease progression.
• Management of blood pressure and proteinuria.
• Hearing aids or cochlear implants for hearing loss.
• Regular monitoring of kidney function, including blood tests and imaging.
• In advanced cases, dialysis or kidney transplantation may be necessary.

Prognosis and Follow-Up

Prognosis varies depending on the genetic form and severity. X-linked males often progress to end-stage renal disease by early adulthood, while females and autosomal forms may have milder or delayed progression. Regular follow-up with nephrology, audiology, and ophthalmology is essential to monitor kidney function, hearing, and eye health. Early intervention can help delay complications.

Complications

• End-stage renal disease requiring dialysis or transplantation.
• Progressive hearing loss.
• Vision problems, including cataracts or retinal damage.
• Hypertension and cardiovascular risks due to kidney disease.

Lifestyle & Prevention

• Maintain a healthy blood pressure through diet and medication.
• Avoid nephrotoxic substances (e.g., certain antibiotics or contrast dyes).
• Protect hearing by avoiding loud noises and using hearing protection.
• Genetic counseling for families to assess inheritance risks and reproductive options.

When to Seek Professional Help

Seek medical attention if you experience persistent blood in urine, unexplained hearing loss, or vision changes. Prompt evaluation is critical for early diagnosis and management, especially in individuals with a family history of Alport syndrome.

Tips for Medical Coders

When coding Alport syndrome (ICD-10-CM code Q87.81), ensure documentation supports the diagnosis, including clinical findings (e.g., hematuria, hearing loss) and genetic testing results if available. Differentiate between X-linked, autosomal recessive, or dominant forms when specified, as this may impact coding accuracy. Verify that associated conditions (e.g., kidney disease, hearing impairment) are coded separately if applicable.